Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 163

1.

BRCA1-associated protein 1 interferes with BRCA1/BARD1 RING heterodimer activity.

Nishikawa H, Wu W, Koike A, Kojima R, Gomi H, Fukuda M, Ohta T.

Cancer Res. 2009 Jan 1;69(1):111-9. doi: 10.1158/0008-5472.CAN-08-3355.

2.

Down-regulation of BRCA1-BARD1 ubiquitin ligase by CDK2.

Hayami R, Sato K, Wu W, Nishikawa T, Hiroi J, Ohtani-Kaneko R, Fukuda M, Ohta T.

Cancer Res. 2005 Jan 1;65(1):6-10.

3.

Functional Link between BRCA1 and BAP1 through Histone H2A, Heterochromatin and DNA Damage Response.

Fukuda T, Tsuruga T, Kuroda T, Nishikawa H, Ohta T.

Curr Cancer Drug Targets. 2016;16(2):101-9. Review.

PMID:
26517537
4.

Activation of the E3 ligase function of the BRCA1/BARD1 complex by polyubiquitin chains.

Mallery DL, Vandenberg CJ, Hiom K.

EMBO J. 2002 Dec 16;21(24):6755-62.

5.

Tuning BRCA1 and BARD1 activity to investigate RING ubiquitin ligase mechanisms.

Stewart MD, Duncan ED, Coronado E, DaRosa PA, Pruneda JN, Brzovic PS, Klevit RE.

Protein Sci. 2017 Mar;26(3):475-483. doi: 10.1002/pro.3091. Epub 2017 Jan 23.

PMID:
27977889
6.

The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation.

Hashizume R, Fukuda M, Maeda I, Nishikawa H, Oyake D, Yabuki Y, Ogata H, Ohta T.

J Biol Chem. 2001 May 4;276(18):14537-40. Epub 2001 Mar 6.

7.

Negative feedback loop of BRCA1-BARD1 ubiquitin ligase on estrogen receptor alpha stability and activity antagonized by cancer-associated isoform of BARD1.

Dizin E, Irminger-Finger I.

Int J Biochem Cell Biol. 2010 May;42(5):693-700. doi: 10.1016/j.biocel.2009.12.025. Epub 2010 Jan 11.

PMID:
20060929
8.

The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by the platinum-based anticancer drugs.

Atipairin A, Canyuk B, Ratanaphan A.

Breast Cancer Res Treat. 2011 Feb;126(1):203-9. doi: 10.1007/s10549-010-1182-7. Epub 2010 Sep 29.

PMID:
20878461
9.

BRCA1 DNA-binding activity is stimulated by BARD1.

Simons AM, Horwitz AA, Starita LM, Griffin K, Williams RS, Glover JN, Parvin JD.

Cancer Res. 2006 Feb 15;66(4):2012-8.

10.
11.

Mass spectrometric and mutational analyses reveal Lys-6-linked polyubiquitin chains catalyzed by BRCA1-BARD1 ubiquitin ligase.

Nishikawa H, Ooka S, Sato K, Arima K, Okamoto J, Klevit RE, Fukuda M, Ohta T.

J Biol Chem. 2004 Feb 6;279(6):3916-24. Epub 2003 Nov 24.

12.

Nucleophosmin/B23 is a candidate substrate for the BRCA1-BARD1 ubiquitin ligase.

Sato K, Hayami R, Wu W, Nishikawa T, Nishikawa H, Okuda Y, Ogata H, Fukuda M, Ohta T.

J Biol Chem. 2004 Jul 23;279(30):30919-22. Epub 2004 Jun 7.

13.

Autoubiquitination of the BRCA1*BARD1 RING ubiquitin ligase.

Chen A, Kleiman FE, Manley JL, Ouchi T, Pan ZQ.

J Biol Chem. 2002 Jun 14;277(24):22085-92. Epub 2002 Apr 1.

14.

The UBXN1 protein associates with autoubiquitinated forms of the BRCA1 tumor suppressor and inhibits its enzymatic function.

Wu-Baer F, Ludwig T, Baer R.

Mol Cell Biol. 2010 Jun;30(11):2787-98. doi: 10.1128/MCB.01056-09. Epub 2010 Mar 29.

15.

Enhancement of BRCA1 E3 ubiquitin ligase activity through direct interaction with the BARD1 protein.

Xia Y, Pao GM, Chen HW, Verma IM, Hunter T.

J Biol Chem. 2003 Feb 14;278(7):5255-63. Epub 2002 Nov 12.

16.

BRCA1-BARD1 complexes are required for p53Ser-15 phosphorylation and a G1/S arrest following ionizing radiation-induced DNA damage.

Fabbro M, Savage K, Hobson K, Deans AJ, Powell SN, McArthur GA, Khanna KK.

J Biol Chem. 2004 Jul 23;279(30):31251-8. Epub 2004 May 24.

17.

Ubiquitination and proteasomal degradation of the BRCA1 tumor suppressor is regulated during cell cycle progression.

Choudhury AD, Xu H, Baer R.

J Biol Chem. 2004 Aug 6;279(32):33909-18. Epub 2004 May 27.

18.

DNA damage-induced BARD1 phosphorylation is critical for the inhibition of messenger RNA processing by BRCA1/BARD1 complex.

Kim HS, Li H, Cevher M, Parmelee A, Fonseca D, Kleiman FE, Lee SB.

Cancer Res. 2006 May 1;66(9):4561-5.

19.

Identification of domains of BRCA1 critical for the ubiquitin-dependent inhibition of centrosome function.

Sankaran S, Starita LM, Simons AM, Parvin JD.

Cancer Res. 2006 Apr 15;66(8):4100-7.

20.

BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression.

Jensen DE, Proctor M, Marquis ST, Gardner HP, Ha SI, Chodosh LA, Ishov AM, Tommerup N, Vissing H, Sekido Y, Minna J, Borodovsky A, Schultz DC, Wilkinson KD, Maul GG, Barlev N, Berger SL, Prendergast GC, Rauscher FJ 3rd.

Oncogene. 1998 Mar 5;16(9):1097-112.

PMID:
9528852

Supplemental Content

Support Center